
News
News | 1 min read
August 5, 2025
After more than a decade of development, a Richmond company is gearing up for a commercial launch of its first product next year.
Tympanogen, a medical device company that is working to modernize medical procedures for ear, nose and throat conditions, is working to go to market with a gel patch to repair perforated eardrums.
To help it get there, the company is looking to raise up to $5 million in investor capital, according to an SEC filing in March. The investment round is led by Philadelphia-based angel investing group Keiretsu Mid-Atlantic and around $1.2 million of that total had been raised at the time of the filing.
Click here to read the full story.